Post-Marketing Surveillance to Evaluate the Safety and Efficacy of Firmagon (Degarelix) for Injection.
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2016
At a glance
- Drugs Degarelix (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors Ferring Pharmaceuticals
- 12 Oct 2016 Status changed from not yet recruiting to recruiting.
- 21 Sep 2016 New trial record